TG Therapeutics | TGTX - 净收入



金融业
股票价格
USD
资产
USD 1.64B
现金及等价物
USD 612.25M
销售成本
USD 41.19M
流动资产
USD 1.15B
流动负债
USD 268.49M
债务
USD 753.56M
EBIT
USD 21.67M
EBITDA
USD 28.11M
员工
338
EPS每股收益
USD 0.05
股本和储备
USD 604.08M
销售毛利
USD 199.14M
债务利息支出
USD 16.57M
贷款资金
USD 745.39M
市值
USD 7.65B
净收入
USD 7.78M
营业费用
USD 218.66M
营业利润
USD 21.67M
普通股股本
USD 155.31M
PE价格收益
19.64
税前利润
USD 10.23M
销售收入
USD 240.34M
销售和管理费用
USD 62.33M
股票
USD 147.97M
贸易债权人
USD 148.85M
应收帐款人
USD 392.05M


净收入 更改 日
AbbVie USD 3.61B 2.92B 2026-06
Alaunos Therapeutics USD -1.01M 153K 2026-03
Amgen USD 2.38B 556M 2026-06
Ardelyx USD -37.6M 37.2M 2026-03
Arrowhead Research USD -132.73M 163.54M 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Biogen USD 97.5M 222M 2026-06
Corcept Therapeutics USD 42.14M 73.9M 2026-06
Curis USD -24.2M 43.56M 2026-03
Gilead Sciences USD -10.5B 12.52B 2026-06
J&J USD 5.53B 299M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Novartis USD 3.26B 108M 2026-06
Novavax USD 17.53M 219.91M 2025-12
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
TG Therapeutics USD 7.78M 12M 2026-06
Verastem USD -36.59M 3.68M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06